DBV Technologies (NSDQ:DBVT) and BioNet-Asia said today that the independent Data & Safety Monitoring Board positively reviewed DBV’s needle-free vaccine patch technology, Viaskin, and that enrollment in a Phase I trial for booster immunization against pertussis will continue into the 2nd dosing cohort. The Viaskin pertussis booster vaccination program will test the ability of DBV’s needle-free vaccine […]
Report: Apple looks at iPhone for monitoring Parkinson’s patients
Apple (NSDQ:AAPL) is reportedly conducting internal research into whether its iPhone and Apple Watch could be used to monitor drug dosage and wellness data for patients suffering from Parkinson’s disease. The company hopes to show the effectiveness of mobile monitoring, sources told Fast Company. Patients who suffer from Parkinson’s disease may only visit their doctor at 6-month intervals, which […]
Delivra president & CFO resigns, names new finance VP | Personnel Moves, Nov. 17, 2016
Delivra Corp. (CVE:DVA) said today that president & CFO Chris Schnarr is resigning effective tomorrow and Pascal Attard has been promoted from controller to VP of finance. Attard has worked as controller for Red Tiger Mining Inc. and manager of McGovern, Hurley, Cunningham LLP prior to joining Delivera in 2015. The Toronto-based company said it is looking […]
New drug capsule delivers medicine for weeks after swallowing
Researchers from Massachusetts Institute of Technology, spurred by a challenge from Bill Gates, developed a star-shaped drug capsule that can gradually release medication and stay in the stomach for to 2 weeks after being swallowed. The study, published yesterday in Science Translational Medicine, described the team’s work using the capsule to deliver an anti-parasitic drug, invermectin, which […]
Adherium touts Smartinhaler asthma study
Adherium (ASK:ADR) touted data from an independent study of its Smartinhaler respiratory disease management tool in children with poorly controlled asthma. The STAAR study was conducted at Sheffield Children’s Hospital in the UK and the results were published this month in Thorax. The New Zealand-based company found that in children with poorly controlled asthma, introducing its […]
Nanoparticle “barcodes” help track cancer drug efficacy
Researchers from Technion Institute of Technology in Israel reported on a method of tagging cancer drugs with “barcodes” to monitor tumor growth. The team detailed their methods in a study published in the November issue of Nature Communications. The nanoparticle drug delivery system are tagged with synthetic DNA, which act as barcodes used to track the tumor’s response […]
Cumberland Pharma acquires U.S. rights to Nordic’s injectable methotrexate
Cumberland Pharmaceuticals (NSDQ:CPIX) said today that it acquired exclusive U.S. rights to Nordic Group‘s injectable methotrexate product line to treat rheumatoid arthritis, juvenile idiopathic arthritis, severe psoriatic arthritis, and severe disabling psoriasis. Nordic Group has registered the product line for patient use in European countries, so Cumberland will register and commercialize the products in the U.S. […]
Cellnovo files 510(k) for connected diabetes management system
Cellnovo (EPA:CLNV) said today that it has filed for 510(k) clearance from the FDA for its diabetes management system. Paris-based Cellnovo touts its system as the 1st mobile, connected diabetes management system. Tubeless and compact, the company’s insulin pump has a mobile touchscreen controller with an integrated blood glucose meter. Data from insulin injections and blood-glucose levels are […]
Bristol-Myers Squibb, Enterome ink immuno-oncology collab
Bristol-Myers Squibb (NYSE:BMY) said today that it inked a collaboration agreement with Enterome to discover and develop microbiome-derived biomarkers and drug targets as potential companion diagnostics and therapeutics for cancer. According to the agreement, Bristol-Myers Squibb will be given exclusive rights to intellectual property and therapies that result from the collaboration. Enterome will get an […]
Handheld breathalyzer as noninvasive blood glucose monitor in development
Researchers from the Western New England University developed a device the size of a small book that diabetes patients can use to monitor their blood glucose levels. Unlike traditional finger-stick testing, this minimally invasive breathalyzer uses acetone levels in patients’ breath to determine blood glucose levels. The team, led by Ronny Priefer and Michael Rust, presented […]